Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$22.67
+0.27%
Mkt Cap $1.68B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$40.00
Range $32.00 – $46.00
Implied Upside
+76.4%
Consensus $40.00 vs current $22.67
NASDAQ·Healthcare·Biotechnology
$22.67
+0.27%
Mkt Cap $1.68B
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$40.00
Range $32.00 – $46.00
+76.4%
Consensus $40.00 vs current $22.67